Medical Cannabis - India

India

India is projected to see a revenue of €209.50m in the Medical Cannabis market market by 2024.
The market is expected to grow annually at a rate of 3.88% from 2024 to 2029, reaching a volume of €253.40m by the end of the period.
When compared globally, the United States will lead in revenue generation, with €13,470.00m expected in 2024.
In terms of per capita revenue, individuals in India are projected to generate €1.94k in 2024.
India's Medical Cannabis market is budding with potential, as regulatory shifts pave the way for increased acceptance and exploration of therapeutic applications.

Key regions: Australia, Europe, South Africa, United States, Netherlands

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

India has seen a gradual shift in attitudes towards medical cannabis, with an increasing number of states legalizing its use for medicinal purposes.

Customer preferences: Patients in India are showing a growing interest in alternative and natural remedies for various health conditions, contributing to the rising demand for medical cannabis products. Additionally, there is a cultural acceptance of traditional herbal medicine in the country, making medical cannabis a favorable choice for some consumers.

Trends in the market: The medical cannabis market in India is witnessing a trend towards the development of a diverse range of products, including oils, tinctures, capsules, and topical solutions. This trend is driven by the increasing awareness of the potential therapeutic benefits of different forms of medical cannabis and the preferences of patients with specific needs.

Local special circumstances: One of the unique aspects of the medical cannabis market in India is the rich history of Ayurveda, a traditional system of medicine that has long emphasized the use of plant-based remedies. This cultural heritage has influenced the acceptance of medical cannabis as a natural treatment option among certain segments of the population.

Underlying macroeconomic factors: The evolving regulatory landscape surrounding medical cannabis in India is a key macroeconomic factor shaping the market. As more states legalize the use of medical cannabis and regulations become clearer, it is expected that the market will continue to expand. Additionally, economic factors such as increasing disposable income and healthcare expenditure are also contributing to the growth of the medical cannabis market in India.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.